Barclays’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-80,000
| Closed | -$6.24M | – | 5052 |
|
|
2024
Q1 | $6.24M | Buy |
+80,000
| New | +$5.95M | ﹤0.01% | 1703 |
|
|
2020
Q2 | – | Sell |
-7,200
| Closed | -$253K | – | 5835 |
|
|
2020
Q1 | $253K | Buy |
7,200
+6,900
| +2,300% | +$329K | ﹤0.01% | 4114 |
|
|
2019
Q4 | $16K | Sell |
300
-42,700
| -99% | -$2.13M | ﹤0.01% | 6025 |
|
|
2019
Q3 | $2.17M | Buy |
43,000
+40,500
| +1,620% | +$1.99M | ﹤0.01% | 2764 |
|
|
2019
Q2 | $120K | Buy |
2,500
+2,400
| +2,400% | +$111K | ﹤0.01% | 5550 |
|
|
2019
Q1 | $5K | Sell |
100
-19,800
| -99% | -$893K | ﹤0.01% | 6708 |
|
|
2018
Q4 | $818K | Buy |
19,900
+2,400
| +14% | +$98.4K | ﹤0.01% | 3319 |
|
|
2018
Q3 | $717K | Sell |
17,500
-53,600
| -75% | -$2.17M | ﹤0.01% | 3963 |
|
|
2018
Q2 | $2.83M | Buy |
71,100
+38,100
| +115% | +$1.47M | ﹤0.01% | 2241 |
|
|
2018
Q1 | $1.23M | Sell |
33,000
-9,100
| -22% | -$368K | ﹤0.01% | 2969 |
|
|
2017
Q4 | $1.8M | Buy |
42,100
+28,700
| +214% | +$1.14M | ﹤0.01% | 2534 |
|
|
2017
Q3 | $492K | Buy |
13,400
+5,200
| +63% | +$210K | ﹤0.01% | 3644 |
|
|
2017
Q2 | $372K | Buy |
+8,200
| New | +$362K | ﹤0.01% | 3811 |
|
|
2017
Q1 | – | Sell |
-13,900
| Closed | -$557K | – | 6839 |
|
|
2016
Q4 | $557K | Sell |
13,900
-100
| -0.7% | -$3.86K | ﹤0.01% | 3273 |
|
|
2016
Q3 | $544K | Buy |
14,000
+100
| +0.7% | +$3.77K | ﹤0.01% | 3145 |
|
|
2016
Q2 | $481K | Buy |
13,900
+4,800
| +53% | +$166K | ﹤0.01% | 3255 |
|
|
2016
Q1 | $309K | Sell |
9,100
-1,300
| -13% | -$45.3K | ﹤0.01% | 3524 |
|
|
2015
Q4 | $395K | Buy |
10,400
+5,400
| +108% | +$210K | ﹤0.01% | 3381 |
|
|
2015
Q3 | $195K | Sell |
5,000
-2,600
| -34% | -$103K | ﹤0.01% | 4155 |
|
|
2015
Q2 | $289K | Buy |
7,600
+700
| +10% | +$24.5K | ﹤0.01% | 3898 |
|
|
2015
Q1 | $228K | Sell |
6,900
-6,000
| -47% | -$184K | ﹤0.01% | 4242 |
|
|
2014
Q4 | $335K | Buy |
12,900
+2,200
| +21% | +$56.8K | ﹤0.01% | 4226 |
|
|
2014
Q3 | $257K | Sell |
10,700
-1,300
| -11% | -$32.8K | ﹤0.01% | 4515 |
|
|
2014
Q2 | $300K | Sell |
12,000
-17,900
| -60% | -$418K | ﹤0.01% | 4433 |
|
|
2014
Q1 | $628K | Sell |
29,900
-483,200
| -94% | -$10.4M | ﹤0.01% | 3722 |
|
|
2013
Q4 | $11.3M | Buy |
513,100
+200
| +0% | +$4.41K | 0.01% | 1160 |
|
|
2013
Q3 | $10.3M | Buy |
512,900
+501,300
| +4,322% | +$10.7M | 0.01% | 1121 |
|
|
2013
Q2 | $224K | Buy |
+11,600
| New | +$242K | ﹤0.01% | 5056 |
|
Other funds holding HOLX
VCM
HI
VPM
Barclays's HOLX Position: Q1 2026 in Review
Barclays increased its Hologic (HOLX) stake by 59% in Q1 2026, buying an estimated $20.8M and bringing the position to 746,127 shares worth $56.4M. The position accounts for 0.01% of the portfolio, ranked #684.
Barclays first reported a position in HOLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $58.5M in Q3 2024. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.
- Barclays held 746,127 shares of Hologic worth $56.4M as of Q1 2026.
- Barclays bought 277,107 Hologic shares in Q1 2026, an estimated $20.8M.
- Hologic made up 0.01% of Barclays's portfolio in Q1 2026, its #684 holding.
- Barclays first reported a position in Hologic in Q2 2013 and has held it in 52 quarters since.
- Barclays's Hologic position peaked at $58.5M in Q3 2024.
- 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.